This site needs JavaScript to work properly. Please enable it to take advantage of the complete set of features!

Skip to main page content

Add to Collections

Your saved search

Name of saved search:

Search terms:

Test search terms

Would you like email updates of new search results?

Yes
No

Email: (change)

Frequency:

Which day?

Which day?

Report format:

Send at most:

Send even when there aren't any new results

Optional text in email:

Your RSS Feed

Comparative Study

. 2006 May;253(5):672-3.

doi: 10.1007/s00415-005-0057-z. Epub 2005 Dec 12.

A novel mutation producing premature termination codon at the OPA1 gene causes autosomal dominant optic atrophy

Elena Cardaioli, Gian Nicola Gallus, Paola Da Pozzo, Alessandra Rufa, Rossella Franceschini, Eduardo Motolese, Aldo Caporossi, Maria T Dotti, Antonio Federico

PMID: 16331355
DOI: 10.1007/s00415-005-0057-z

Comparative Study

A novel mutation producing premature termination codon at the OPA1 gene causes autosomal dominant optic atrophy

Elena Cardaioli et al. J Neurol. 2006 May.

. 2006 May;253(5):672-3.

doi: 10.1007/s00415-005-0057-z. Epub 2005 Dec 12.

Authors

Elena Cardaioli, Gian Nicola Gallus, Paola Da Pozzo, Alessandra Rufa, Rossella Franceschini, Eduardo Motolese, Aldo Caporossi, Maria T Dotti, Antonio Federico

PMID: 16331355
DOI: 10.1007/s00415-005-0057-z

No abstract available

PubMed Disclaimer

Similar articles

Comprehensive cDNA study and quantitative transcript analysis of mutant OPA1 transcripts containing premature termination codons.
Schimpf S, Fuhrmann N, Schaich S, Wissinger B. Schimpf S, et al. Hum Mutat. 2008 Jan;29(1):106-12. doi: 10.1002/humu.20607. Hum Mutat. 2008. PMID: 17722006
Dominant optic atrophy caused by a novel OPA1 splice site mutation (IVS20+1G-->A) associated with intron retention.
Hayashi T, Gekka T, Omoto S, Takeuchi T, Kitahara K. Hayashi T, et al. Ophthalmic Res. 2005 Jul-Aug;37(4):214-24. doi: 10.1159/000086862. Epub 2005 Jul 5. Ophthalmic Res. 2005. PMID: 16006781
Fourteen novel OPA1 mutations in autosomal dominant optic atrophy including two de novo mutations in sporadic optic atrophy.
Baris O, Delettre C, Amati-Bonneau P, Surget MO, Charlin JF, Catier A, Derieux L, Guyomard JL, Dollfus H, Jonveaux P, Ayuso C, Maumenee I, Lorenz B, Mohammed S, Tourmen Y, Bonneau D, Malthièry Y, Hamel C, Reynier P. Baris O, et al. Hum Mutat. 2003 Jun;21(6):656. doi: 10.1002/humu.9152. Hum Mutat. 2003. PMID: 14961560
Recessive optic atrophy, sensorimotor neuropathy and cataract associated with novel compound heterozygous mutations in OPA1.
Lee J, Jung SC, Hong YB, Yoo JH, Koo H, Lee JH, Hong HD, Kim SB, Chung KW, Choi BO. Lee J, et al. Mol Med Rep. 2016 Jul;14(1):33-40. doi: 10.3892/mmr.2016.5209. Epub 2016 May 4. Mol Med Rep. 2016. PMID: 27150940 Free PMC article. Review.
OPA1 (Kjer type) dominant optic atrophy: a novel mitochondrial disease.
Delettre C, Lenaers G, Pelloquin L, Belenguer P, Hamel CP. Delettre C, et al. Mol Genet Metab. 2002 Feb;75(2):97-107. doi: 10.1006/mgme.2001.3278. Mol Genet Metab. 2002. PMID: 11855928 Review.

See all similar articles

Cited by

Mitochondrial Mutations in Ethambutol-Induced Optic Neuropathy.
Zhang XH, Xie Y, Xu QG, Cao K, Xu K, Jin ZB, Li Y, Wei SH. Zhang XH, et al. Front Cell Dev Biol. 2021 Oct 5;9:754676. doi: 10.3389/fcell.2021.754676. eCollection 2021. Front Cell Dev Biol. 2021. PMID: 34676220 Free PMC article.
OPA1 Dominant Optic Atrophy: Diagnostic Approach in the Pediatric Population.
Arruti N, Rodríguez-Solana P, Nieves-Moreno M, Guerrero-Carretero M, Del Pozo Á, Montaño VEF, Santos-Simarro F, Rikeros-Orozco E, Delgado-Mora L, Vallespín E, Noval S. Arruti N, et al. Curr Issues Mol Biol. 2023 Jan 5;45(1):465-478. doi: 10.3390/cimb45010030. Curr Issues Mol Biol. 2023. PMID: 36661516 Free PMC article.
A phenotypic variation of dominant optic atrophy and deafness (ADOAD) due to a novel OPA1 mutation.
Liguori M, La Russa A, Manna I, Andreoli V, Caracciolo M, Spadafora P, Cittadella R, Quattrone A. Liguori M, et al. J Neurol. 2008 Jan;255(1):127-9. doi: 10.1007/s00415-008-0571-x. Epub 2008 Jan 22. J Neurol. 2008. PMID: 18204809 No abstract available.

References

1. Mol Genet Metab. 2002 Feb;75(2):97-107 - PubMed
1. Hum Mol Genet. 2001 Jun 15;10(13):1359-68 - PubMed
1. J Neurol Neurosurg Psychiatry. 2004 Dec;75(12):1731-6 - PubMed
1. Br J Ophthalmol. 2003 Jan;87(1):48-53 - PubMed
1. Jpn J Ophthalmol. 2002 May-Jun;46(3):336-40 - PubMed

Publication types

Actions
Actions

MeSH terms

Actions
Actions
Actions
Actions
Actions
Actions
Actions
Actions
Actions
Actions
Actions
Actions

Substances

Actions
Actions
Actions
Actions

LinkOut - more resources

Full Text Sources
- Ovid Technologies, Inc.
- Springer